Grant: Project Grant
University of Manitoba
$1,059,526.00
Novel actions of antagonists at muscarinic acetylcholine type 1 receptors
EF 2025-26
Résumé
Diseases of the peripheral nervous have a huge impact on quality of life of persons. For example, diabetes and chemotherapy cause direct damage to peripheral nerves controlling sensation. This can lead to intractable pain and/or loss of sensation. There are no treatments for these diseases that can reverse this neurodegeneration. Therapies for pain are expensive and drive complex and difficult to manage side effects. We have discovered that drugs that block the function of a specific receptor on sensory neurons can enhance nerve regeneration. In animal models of human disease, these drugs can reverse pain and sensory loss. In addition, we have preliminary evidence these drugs are safe and show some efficacy in humans with diabetes. Limiting our progress is a clear understanding of the exact function of these drugs at specific receptors on sensory neurons. In the current proposal we will use cutting edge pharmacological and cell biological techniques to investigate how these drugs work. We hope a better understanding of the pharmacological actions of these drugs might drive design of novel drugs for treatment of these debilitating diseases.
Programme
Project Grant
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
564395
Name
Fernyhough Paul
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Pharmacology & Toxicology
Projecttitle
Novel actions of antagonists at muscarinic acetylcholine type 1 receptors
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$1,059,526
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Mitochondrial Function; Muscarinic Receptor; Neuropathy; Sensory Neuron
Abstract
Diseases of the peripheral nervous have a huge impact on quality of life of persons. For example, diabetes and chemotherapy cause direct damage to peripheral nerves controlling sensation. This can lead to intractable pain and/or loss of sensation. There are no treatments for these diseases that can reverse this neurodegeneration. Therapies for pain are expensive and drive complex and difficult to manage side effects. We have discovered that drugs that block the function of a specific receptor on sensory neurons can enhance nerve regeneration. In animal models of human disease, these drugs can reverse pain and sensory loss. In addition, we have preliminary evidence these drugs are safe and show some efficacy in humans with diabetes. Limiting our progress is a clear understanding of the exact function of these drugs at specific receptors on sensory neurons. In the current proposal we will use cutting edge pharmacological and cell biological techniques to investigate how these drugs work. We hope a better understanding of the pharmacological actions of these drugs might drive design of novel drugs for treatment of these debilitating diseases.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Fernyhough, Paul
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,059,526~ $0~